IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding IO Biotech, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 29.7M | 29.4M | −267.9K (−0.9%) |
| Value | $41.7M | $55.3M | +$13.6M (+32.5%) |
New holders (3)
Institutions that held IO Biotech, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 51,867 | $97.5K | 0.00% |
| UBS Group AG | 11,204 | $21.1K | 0.00% |
| Comerica Bank | 2 | $4 | 0.00% |
Sold out (4)
Institutions that held IO Biotech, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Avoro Capital Advisors LLC | 2,055,883 | $2.84M |
| Alyeska Investment Group, L.P. | 987,654 | $1.39M |
| XTX Topco Ltd | 21,238 | $29.3K |
| Ancora Advisors, LLC | 908 | $1.28K |